Clinical trial
Topical FK506 (Tacrolimus) for Prevention of Immune Reactions Following Penetrating Keratoplasty
NCT00463723 is registered in ClinicalTrials.gov with University Hospital Freiburg as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Topical FK506 (Tacrolimus) for Prevention of Immune Reactions Following Penetrating Keratoplasty
- Lead sponsor
- University Hospital Freiburg
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
penetrating keratoplasty